Skip to main content
Fig. 1 | Pilot and Feasibility Studies

Fig. 1

From: Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania

Fig. 1

Schedule of events

WK denotes week

$ The safety parameters includes Hematology: hemoglobin, hematocrit, red blood cell count, white blood cell count with differential, platelet count. Clinical Chemistry: Albumin, urea, creatinine, direct, indirect and total bilirubin, uric acid, total protein, ALP, AST, ALT, gamma‐glutamyl transferase (GGT), lactate dehydrogenase (LDH), phosphate, sodium, potassium, calcium (corrected for albumin), chloride, random/fasting glucose, bicarbonate/CO2

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784